Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.

× No keyword cloud information.

10 in total

1. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

Authors: Lennox K Archibald; Shailen N Banerjee; William R Jarvis
Journal: J Infect Dis Date: 2004-04-20 Impact factor: 5.226

2. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec.

Authors: Karl Weiss
Journal: Clin Infect Dis Date: 2006-03-01 Impact factor: 9.079

3. Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning.

Authors: Mathieu Beaulieu; Daniel J G Thirion; David Williamson; Gilbert Pichette
Journal: Clin Infect Dis Date: 2006-03-01 Impact factor: 9.079

4. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors: Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal: N Engl J Med Date: 2005-12-01 Impact factor: 91.245

5. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors: Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal: JAMA Date: 2005-12-21 Impact factor: 56.272

6. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors: Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal: Clin Infect Dis Date: 2005-09-20 Impact factor: 9.079

7. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.

Authors: Sandra Dial; J A Chris Delaney; Verena Schneider; Samy Suissa
Journal: CMAJ Date: 2006-09-26 Impact factor: 8.262

8. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors: Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal: CMAJ Date: 2004-08-31 Impact factor: 8.262

9. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

Authors: R Cunningham; B Dale; B Undy; N Gaunt
Journal: J Hosp Infect Date: 2003-07 Impact factor: 3.926

10. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors: Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal: CMAJ Date: 2004-07-06 Impact factor: 8.262

10 in total

2 in total

1. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

Authors: Tadayuki Oshima; Liping Wu; Min Li; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal: J Gastroenterol Date: 2017-07-25 Impact factor: 7.527

2. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.

Authors: Sahil Khanna; Scott L Aronson; Patricia P Kammer; Larry M Baddour; Darrell S Pardi
Journal: Mayo Clin Proc Date: 2012-07 Impact factor: 7.616

2 in total